Biotech Financing update - March - May 2020

UK biotech financing since the beginning of March has been very positive.* Total investments of £585m have been made, driven by later-stage private deals and follow-on financings on the public markets.

COVID-19 appears to have hit early-stage private financings, however, with many deals being abandoned or paused as investors wait to see the full impact of the pandemic.

A total of £894m has now been raised from all sources in the first half of 2020, surpassing the £831m raised in the same period in 2018, which was a record-breaking year.